Skip to main content
Top

03-02-2025 | Type 1 Diabetes | Original Article

Impact of a COVID-19 emergency declaration on blood glucose levels in individuals with type 1 diabetes treated with a sensor-augmented pump

Authors: Tomofumi Takayoshi, Yushi Hirota, Akane Yamamoto, Kai Yoshimura, Seiji Nishikage, Mariko Ueda, Wataru Ogawa

Published in: Diabetology International

Login to get access

Abstract

Introduction

COVID-19 emergency declarations and ensuing lockdowns affected lifestyle and glycemic control in individuals with diabetes mellitus, with some studies finding improvement and others deterioration of glucose management. The effects of such emergency declarations in Asian populations, including individuals with type 1 diabetes (T1D) managed with a sensor-augmented pump (SAP), have been unclear, however. We here investigated the impact of a COVID-19 emergency declaration on glycemic control in Japanese individuals with T1D treated with a SAP device.

Methods

This retrospective investigation included individuals with T1D who were managed with SAP technology and had continuous glucose monitoring including sensor glucose levels and time above range, time in range [TIR], and time below range and insulin dose data available in electronic health records from February to July 2020, corresponding to periods before, during, and after the declared emergency.

Results

The 78 enrolled individuals had a mean age of 44.6 years, diabetes duration of 15.4 years, and hemoglobin A1c level of 7.3%. Average sensor glucose levels improved from 152.0 mg/dL before to 148.0 mg/dL during and 147.6 mg/dL after the emergency. TIR increased from 68.8% before to 71.3% during and 71.4% after the emergency. Total daily insulin dose decreased from 40.9 U before to 39.6 U after the emergency. After the emergency declaration, individuals with an initial TIR of ≤ 70% showed increased sensor adherence as well as a greater improvement in glycemic control compared with those with a TIR of > 70%.

Conclusion

Individuals with T1D treated with a SAP device showed improved glycemic management after the COVID-19 emergency declaration.
Appendix
Available only for authorised users
Literature
1.
go back to reference Martínez-de-Quel Ó, Suárez-Iglesias D, López-Flores M, et al. Physical activity, dietary habits and sleep quality before and during COVID-19 lockdown: a longitudinal study. Appetite. 2021;158: 105019.CrossRefPubMed Martínez-de-Quel Ó, Suárez-Iglesias D, López-Flores M, et al. Physical activity, dietary habits and sleep quality before and during COVID-19 lockdown: a longitudinal study. Appetite. 2021;158: 105019.CrossRefPubMed
2.
go back to reference Terakawa A, Bouchi R, Kodani N, et al. Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID-19 pandemic: a retrospective observational study. J Diabetes Investig. 2022;13:1094–104.CrossRefPubMedPubMedCentral Terakawa A, Bouchi R, Kodani N, et al. Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID-19 pandemic: a retrospective observational study. J Diabetes Investig. 2022;13:1094–104.CrossRefPubMedPubMedCentral
3.
go back to reference Munekawa C, Hosomi Y, Hashimoto Y, et al. Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study. Endocr J. 2021;68:201–10.CrossRefPubMed Munekawa C, Hosomi Y, Hashimoto Y, et al. Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study. Endocr J. 2021;68:201–10.CrossRefPubMed
4.
go back to reference Hosomi Y, Munekawa C, Hashimoto Y, et al. The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study. Diabetol Int. 2021;13:85–90.CrossRefPubMedPubMedCentral Hosomi Y, Munekawa C, Hashimoto Y, et al. The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study. Diabetol Int. 2021;13:85–90.CrossRefPubMedPubMedCentral
5.
go back to reference Onishi Y, Yoshida Y, Takao T, et al. Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan. J Diabetes Investig. 2022;13:386–90.CrossRefPubMed Onishi Y, Yoshida Y, Takao T, et al. Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan. J Diabetes Investig. 2022;13:386–90.CrossRefPubMed
6.
go back to reference Bouchi R, Sugiyama T, Goto A, et al. Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: a multicenter retrospective observational study. J Diabetes Investig. 2023;14:994–1004.CrossRefPubMedPubMedCentral Bouchi R, Sugiyama T, Goto A, et al. Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: a multicenter retrospective observational study. J Diabetes Investig. 2023;14:994–1004.CrossRefPubMedPubMedCentral
7.
go back to reference Ruiz-Roso MB, Knott-Torcal C, Matilla-Escalante DC, et al. COVID-19 lockdown and changes of the dietary pattern and physical activity habits in a cohort of patients with type 2 diabetes mellitus. Nutrients. 2020;12:2327.CrossRefPubMedPubMedCentral Ruiz-Roso MB, Knott-Torcal C, Matilla-Escalante DC, et al. COVID-19 lockdown and changes of the dietary pattern and physical activity habits in a cohort of patients with type 2 diabetes mellitus. Nutrients. 2020;12:2327.CrossRefPubMedPubMedCentral
8.
go back to reference Tanaka N, Hamamoto Y, Kurotobi Y, et al. Lifestyle changes as a result of COVID-19 containment measures: bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency. J Diabetes Investig. 2021;12:1718–22.CrossRefPubMedPubMedCentral Tanaka N, Hamamoto Y, Kurotobi Y, et al. Lifestyle changes as a result of COVID-19 containment measures: bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency. J Diabetes Investig. 2021;12:1718–22.CrossRefPubMedPubMedCentral
9.
go back to reference Önmez A, Gamsızkan Z, Özdemir Ş, et al. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes Metab Syndr. 2020;14:1963–6.CrossRefPubMedPubMedCentral Önmez A, Gamsızkan Z, Özdemir Ş, et al. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes Metab Syndr. 2020;14:1963–6.CrossRefPubMedPubMedCentral
10.
go back to reference Rastogi A, Hiteshi P, Bhansali A. Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study. Int J Diabetes Dev Ctries. 2020;40:476–81.CrossRefPubMed Rastogi A, Hiteshi P, Bhansali A. Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study. Int J Diabetes Dev Ctries. 2020;40:476–81.CrossRefPubMed
11.
go back to reference Capaldo B, Annuzzi G, Creanza A, et al. Blood glucose control during lockdown for COVID-19: CGM metrics in Italian adults with type 1 diabetes. Diabetes Care. 2020;43:e88–9.CrossRefPubMedPubMedCentral Capaldo B, Annuzzi G, Creanza A, et al. Blood glucose control during lockdown for COVID-19: CGM metrics in Italian adults with type 1 diabetes. Diabetes Care. 2020;43:e88–9.CrossRefPubMedPubMedCentral
12.
go back to reference Viñals C, Mesa A, Roca D, et al. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump. Acta Diabetol. 2021;58:383–8.CrossRefPubMed Viñals C, Mesa A, Roca D, et al. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump. Acta Diabetol. 2021;58:383–8.CrossRefPubMed
13.
go back to reference Lal A, Abdalla SM, Chattu VK, et al. Pandemic preparedness and response: exploring the role of universal health coverage within the global health security architecture. Lancet Glob Health. 2022;10:e1675–83.CrossRefPubMedPubMedCentral Lal A, Abdalla SM, Chattu VK, et al. Pandemic preparedness and response: exploring the role of universal health coverage within the global health security architecture. Lancet Glob Health. 2022;10:e1675–83.CrossRefPubMedPubMedCentral
14.
go back to reference Fernández E, Cortazar A, Bellido V. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2020;166: 108348.CrossRefPubMedPubMedCentral Fernández E, Cortazar A, Bellido V. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2020;166: 108348.CrossRefPubMedPubMedCentral
15.
go back to reference Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed
16.
go back to reference Bergenstal RM, Tamborlane WV, Ahmann A, STAR 3 Study Group, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311–20.CrossRefPubMed Bergenstal RM, Tamborlane WV, Ahmann A, STAR 3 Study Group, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311–20.CrossRefPubMed
Metadata
Title
Impact of a COVID-19 emergency declaration on blood glucose levels in individuals with type 1 diabetes treated with a sensor-augmented pump
Authors
Tomofumi Takayoshi
Yushi Hirota
Akane Yamamoto
Kai Yoshimura
Seiji Nishikage
Mariko Ueda
Wataru Ogawa
Publication date
03-02-2025
Publisher
Springer Nature Singapore
Published in
Diabetology International
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-025-00802-4

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more